The Karnataka High Court recently quashed criminal proceedings against pharmaceutical retail chain MedPlus and its officials over an alleged excess collection of ₹1.12 from a customer who was supplied seven tablets instead of eight [M/s MedPlus & others v. State of Karnataka].
In a verdict delivered on November 13, Justice S Vishwajith Shetty held that the prosecution would cause “embarrassment” to the accused.
Hence, it allowed two petitions filed by MedPlus and its officials, ruling that the allegations did not satisfy the essential ingredients of the offence under the Drugs (Price Control) Order, 2013.
The Court observed that the alleged short supply of one tablet, coupled with the collection of ₹1.12, did not establish that the accused had sold the drug at a price exceeding the permissible ceiling price.
The case arose from a purchase of Lanzol Junior 15 mg tablets by one Shrinath Joshi, a Senior Reporter with ETV Kannada News, on August 23, 2016.
According to the private complaint filed by the Assistant Drugs Controller of Bengaluru, MedPlus had raised a bill for ₹40.32 towards eight tablets but supplied only seven. The complainant alleged that the pharmacy had thereby collected an excess amount of ₹1.12.
Following a complaint lodged by Joshi on August 26, 2016, criminal proceedings were initiated against MedPlus and its officials.
The prosecution invoked Clause 26 of the Drugs (Price Control) Order, 2013, read with Section 7 of the Essential Commodities Act, 1955.
Aggrieved by the proceedings, MedPlus, its director P Srinivas and two other officials, Sudhakar Reddy and Rangaswamy K, approached the High Court seeking to quash the case.
The High Court examined whether the short supply of one tablet and the collection of ₹1.12 could constitute an offence under Clause 26 of the Drugs (Price Control) Order, 2013.
Clause 26 prohibits the sale of a drug formulation to a consumer at a price exceeding the price specified in the current price list or the price indicated on the label of the container or pack, whichever is lower.
The Court observed that the offence would be attracted only when a person sells a drug formulation at a price exceeding the applicable price ceiling or the price indicated on the label.
In the present case, however, the prosecution's allegation was that the accused had supplied seven tablets instead of eight and collected an additional ₹1.12 from the complainant.
The Court pointed out that the prosecution had not alleged that the accused had collected an amount exceeding the price indicated on the label of the container or pack.
Consequently, the essential ingredients required to attract Clause 26 of the Drugs (Price Control) Order, 2013, were not made out against the accused, the Court held.
It further concluded that permitting the criminal prosecution to continue in the absence of the necessary ingredients of the alleged offence would be unjustified and amount to abuse of process of law
Hence, it allowed the petitions and quashed the criminal proceedings against MedPlus and its officials.
Advocate Akki Manjunath Gowda K appeared for the petitioners. High Court Government Pleader Rahul Rai K appeared for the State.
[Read Judgement]